Warm sparse-dense wave inhibits cartilage degradation in papain-induced osteoarthritis through the mitogen-activated protein kinase signaling pathway

Abstract

Cartilage degradation is an important in the pathogenesis of osteoarthritis (OA). Abnormal activation of the mitogen-activated protein kinase (MAPK) signaling pathway in chondrocytes promotes an inflammatory response, resulting in the release of chondral matrix-degrading enzymes that accelerate the degradation of cartilage. As a non-pharmaceutical and non-invasive physical therapy regimen, warm sparse-dense wave (WSDW) has been successfully used for the treatment of OA. However, it remains unclear whether WSDW inhibits cartilage degradation in OA through the MAPK signaling pathway. The present study investigated the effects of WSDW on papain-induced OA in rat knee joints. Papain-induced OA was established in rats, which were subsequently divided into a model group and three experimental groups that received a WSDW with the following ratios: WSDW=1:1, WSDW=1:2 and WSDW=2:1. After 12 weeks of treatment, cartilage degradation was evaluated by Mankin scoring of paraffin-embedded sections stained with hematoxylin and eosin. The changes in cartilage structure were observed by transmission electron microscopy, and the expressions of RAS, extracellular signal-regulated kinase (ERK), p38 and p53 were measured by reverse transcription-quantitative polymerase chain reaction and western blot analysis. WSDW was demonstrated to improve the arrangement of collagen fibers, inhibit the tidemark replication and delay cartilage degradation in papain-induced OA. The expressions of RAS, ERK, p38 and p53 in the WSDW (1:2) and (2:1) groups were significantly decreased when compared with the model group (P<0.01). Furthermore, amongst the WSDW groups, the inhibitory effects of the WSDW (1:2) group were typically greater than those of the WSDW (1:1) and (2:1) groups. The results indicate that WSDW may inhibit cartilage degradation in papain-induced OA in rat knee joints by regulating the MAPK signaling pathway.

Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy

“…For example, the PI3K/Akt pathway regulates the activation of T and B lymphocytes. 27 In addition, both the expression and phosphorylation levels of Akt are higher in LN than those in healthy donors, in favor of an upregulation of PI3K and mTOR activity. 28 Similarly, in terms of IgA patients, the PI3K-Akt-mTOR pathway is activated in their podocytes, which can reduce the level of autophagy in podocytes and lead to podocyte injury.…”

Potential Therapeutic Mechanism of Radix Angelicae Biseratae and Dipsaci Radix Herb Pair against Osteoarthritis: Based on Network Pharmacology and Molecular Docking

“…Researchers have demonstrated that the PI3K/AKT pathway that involves AKT1 prevents chondrocyte apoptosis [58]. TP53 inhibits DNA replication, induces apoptosis, and accelerates cartilage degradation [59]. In addition, researchers have demonstrated that the VEGFA is closely associated with many pathological responses, such as osteophyte formation and cartilage degeneration in OA [60].…”

Discussion on the molecular mechanism of Duhuo Jisheng decoction in treating osteoarthritis based on network pharmacology and molecular docking

“…Inhibition of the HSP90 protein can improve cartilage degeneration and prevent the development of OA. [ 40 ] TP53 is an important tumor suppressor gene. The encoded protein P53, which regulates the cell cycle, DNA repair, apoptosis, and signal transduction, is a main factor involved in cell stress reactions.…”